Products
Stenocare offers medical cannabis oil products.
stenocare.comCrawled Nov 21, 2026
Stenocare offers medical cannabis oil products.
100 mg/mL CBD30 mL bottle Approval date: 16.12.2024 CBD100 OIL STENOCARE is included on the Danish Medicines Agency’s list of cannabis products for medical use. CBD100 OIL STENOCARE s available only on prescription through a doctor for dispensing at a Danish pharmacy. For patient information sheets on the Danish Medicines Agency’s website klik her For [...]Read More...
Medical cannabis includes cannabis plant extracts or synthetic cannabinoids for conditions like sclerosis and cancer.
Medical cannabis may relieve pain, stimulate appetite, and reduce nausea, though evidence remains limited.
Stenocare’s approved products include THC oil, THC/CBD oil, CBD oil, and high-CBD100 oil.
In Denmark, medical cannabis requires a prescription and can only be bought at pharmacies.
Dosage for medical cannabis varies by patient and requires individual adjustment.
Medical cannabis under the pilot programme lacks systematic study, so evidence of side effects is limited.
While 2023 has shown success in Denmark in terms of sales volume, leading to all time high actual sales, it is equally important to point out that sales are expected to reach 15mDKKK in 2024 (+/-20%) leading to projected break-even by end 2024. This outlook is based upon a number of sources and strategic initiatives [...]Read More...
Stenocare’s Extraordinary General Meeting was held on November 18, 2022, in Copenhagen.
Stenocare’s Astrum 10-10 medical cannabis product is approved for sale in Norway.
The subscription period for Stenocare’s share issue closed on January 20, 2025.
Stenocare closed the compensation period for TO1 Warrant holders on January 12, 2024.
Stenocare develops medical cannabis oils based on Danish pharmaceutical traditions.
STENOCARE is a Danish company that cultivate, produce, import and sell prescription-based medical cannabis.
Stenocare processes personal data in compliance with EU rules.